US Federal 2023-2024 Regular Session

US Federal House Bill HB1173

Introduced
2/24/23  
Refer
2/24/23  

Caption

Patients’ Right to Know Their Medication Act of 2023

Impact

If enacted, HB 1173 would require that PMI be provided in a standardized format that is clear and easily understandable for patients. The regulations would stipulate that this vital information should include safety warnings, directions for use, and details about potential drug interactions, specifically tailored to various demographics such as children and elderly patients. Notably, the bill mandates that this information be provided in paper format for accessibility, as many patients may not have reliable access to electronic versions. This legislative shift aims to foster better patient compliance and reduce both emergency room visits and hospital admissions stemming from misuse of medications, forecasting a potential cost reduction of billions annually in related healthcare expenses.

Summary

House Bill 1173, titled the Patients’ Right to Know Their Medication Act of 2023, seeks to amend the Federal Food, Drug, and Cosmetic Act to enhance the patient medication information (PMI) that must accompany prescription drugs. The bill recognizes the importance of patient safety in the administration of medications, particularly given that nearly half of Americans use prescription drugs. It emphasizes the necessity for accessible, accurate, and user-friendly medication information to aid patients in understanding the risks and proper use of their medications. This initiative is aimed at mitigating adverse drug events, which can lead to significant healthcare costs.

Contention

There may be points of contention surrounding the implementation of HB 1173, primarily pertaining to the logistics and costs associated with printing and distributing the standardized PMI. Critics might argue about the financial impact on pharmaceutical companies and healthcare providers, necessitating additional resources for compliance. There may also be concerns over the effectiveness of the mandated PMI in truly improving patient understanding and medication adherence, raising questions about the best methods to communicate important health information. Ultimately, this bill seeks to strike a balance between patient safety and the practical implications for drug manufacturers and healthcare providers.

Companion Bills

No companion bills found.

Previously Filed As

US HB5133

Patients’ Right to Know Their Medication Act of 2025

US HB3472

OPIOID PATIENTS RIGHT TO KNOW

US SB104

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; To Protect Patients' Rights And Access To Medications; And To Declare An Emergency.

US HB2471

Right Drug Dose Now Act of 2025

US HB2092

SPEAK Act of 2025 Supporting Patient Education And Knowledge Act of 2025

US HB2537

Relating To The Patients' Bill Of Rights.

US SB3027

Relating To The Patients' Bill Of Rights.

US HB1600

Health care; Lori Brand Patient Bill of Rights Act of 2025; rights of patient; responsibilities of patients; rights of minors; responsibilities of parents; effective date.

US HB1600

Health care; Lori Brand Patient Bill of Rights Act of 2025; rights of patient; responsibilities of patients; rights of minors; responsibilities of parents; effective date.

US HB5316

Drug Shortage Compounding Patient Access Act of 2025

Similar Bills

No similar bills found.